NCT04361045 is a NA clinical trial of StriveWeekly in Anxiety, sponsored by University of California, Los Angeles.

Who is sponsoring NCT04361045?

NCT04361045 is sponsored by University of California, Los Angeles.

What drugs are being tested in NCT04361045?

Interventions in NCT04361045: StriveWeekly.

What condition does NCT04361045 study?

NCT04361045 studies Anxiety, Depressive Symptoms, Stress, Psychological.

Is NCT04361045 still recruiting?

NCT04361045 is currently completed. Last updated 17 May 2023.

Last reviewed 2023-05-17 · How we verify

NCT04361045

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

StriveWeekly: Self-Guided Online Intervention for Anxiety, Depression, and Stress in University Students

Completed NA Last updated 17 May 2023

What this trial tests

NA trial testing StriveWeekly in Anxiety in 1,631 participants. Completed in 18 March 2018.

Timeline

14 September 2017

Primary endpoint
18 March 2018

18 March 2018

Quick facts

Lead sponsor	University of California, Los Angeles
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	1,631
Start date	14 September 2017
Primary completion	18 March 2018
Estimated completion	18 March 2018
Sites	1 location across United States

Drugs / interventions tested

StriveWeekly

Conditions studied

Anxiety — all drugs for Anxiety →
Depressive Symptoms — all drugs for Depressive Symptoms →
Stress, Psychological — all drugs for Stress, Psychological →

Sponsor

University of California, Los Angeles

Who can join

18 and older, any sex, with Anxiety or Depressive Symptoms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was a randomized controlled trial of an original online mental health promotion program. This study aimed to: 1) establish program effectiveness by examining symptom change between conditions and 2) examine predictors of symptom change. The program was previously tested in open trial feasibility study by the same Principal Investigator and has since been rebuilt as informed by feasibility findings and participant qualitative feedback. Participants were randomly assigned to either a waitlist condition or eight weeks of the intervention condition. Baseline, posttest, and follow-up electronic surveys collected self-reported symptoms of stress, anxiety, and depression. Motivational variables were also assessed at baseline and then tested as moderators of intervention effects.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Measuring Adherence Within a Self-Guided Online Intervention for Depression and Anxiety: Secondary Analyses of a Randomized Controlled Trial.
Hanano M, Rith-Najarian L, Boyd M, Chavira D. · · 2022 · cited 19× · PMID 35343901 · DOI 10.2196/30754
Motivational Variables as Moderating Effects of a Web-Based Mental Health Program for University Students: Secondary Analysis of a Randomized Controlled Trial.
Hanano M, Rith-Najarian L, Gong-Guy E, Chavira D. · · 2024 · cited 3× · PMID 38959024 · DOI 10.2196/56118

Verify or expand the search:

Other trials of StriveWeekly

Trials testing the same drug.

NCT04927845 — StriveWeekly Online Mental Health Trial Post-pandemic · NA · completed

Other recruiting trials for Anxiety

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting
NCT07466875 — Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients · NA · recruiting
NCT07425951 — Building Cognitive Behavioural Skills With StoryBooks to Reduce Emotional Difficulties in Kindergarten Years · NA · recruiting
NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting

Other University of California, Los Angeles trials

Trials by the same sponsor.

NCT04846517 — rTMS for Aneroxia Nervosa in Youth · NA · not yet recruiting
NCT06701760 — Sodium Lactate in Severe TBI · Phase 2 · not yet recruiting
NCT04996667 — Effect of iNO in Patients With Submassive and Massive PE · Phase 2 · withdrawn
NCT05067387 — Evaluation of Oral THC and CBD in Men and Women · Phase 1 · not yet recruiting
NCT07534696 — Evaluation of Non-Invasive Pelvic Floor Neuromuscular Stimulation for Urinary Incontinence After Prostatectomy · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04361045 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, Los Angeles
Last refreshed: 17 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04361045.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing